禁食C-与糖尿病持续时间比率 (FCP/DD) 和糖尿病外围神经病变之间的关系
Yueyue Fu1, Yuling Xing2, Linlin Yang3
1Graduate School of North China University of Science and Technology, Tangshan, People's Republic of China.
Diabetes, metabolic syndrome and obesity : targets and therapy
|December 2, 2024
概括
在2型糖尿病患者中,高的禁食C与糖尿病持续时间比率 (FCP/DD) 有助于预防糖尿病外围神经病变 (DPN). 这个比率比单独的FCP或DD更好地预测DPN.
科学领域:
- 内分泌学 在内分泌学.
- 神经学 神经学
- 代谢疾病 代谢疾病
背景情况:
- 糖尿病外围神经病变 (DPN) 是2型糖尿病 (T2DM) 的常见并发症.
- 对DPN的预测标记对于早期干预和管理至关重要.
- 禁食C与糖尿病持续时间比率 (FCP/DD) 已成为比特细胞功能与疾病进展相对的潜在指标.
研究的目的:
- 调查FCP/DD比率与T2DM患者中DPN的存在之间的相关性.
- 评估FCP/DD比率对DPN与其单个组件相比的预测能力.
主要方法:
- 一组816名T2DM患者被分为DPN (n=408) 和非DPN (n=408) 组.
- 收集了包括FCP和糖尿病持续时间 (DD) 在内的基线数据,以计算FCP/DD比率.
- 进行了统计分析,以比较组,并评估FCP/DD对DPN的相关性和预测值.
主要成果:
- 与非DPN组相比,DPN患者的FCP/DD比率,FCP水平和eGFR明显较低.
- 低FCP/DD比率与年龄增加,糖尿病持续时间长,高血压,DPN和糖尿病相关并发症的患病率更高有关.
- 与单独使用FCP (AUC=0.587) 或DD (AUC=0.665) 相比,FCP/DD比率显示了DPN (AUC=0.737) 的优异预测性能.
结论:
- 高FCP/DD比率是T2DM中对DPN的重要保护因素.
- FCP/DD比率作为T2DM中DPN发生的更有效的预测指标,而不是单独的FCP或DD.
相关概念视频
Diabetes: Symptoms, Diagnosis, and Complications
504
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
504
Diabetes Mellitus: Type 2 and Gestational
2.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K
Pathophysiology of Diabetes
866
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
866
Carbohydrate Metabolism
10.8K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
10.8K
Hypoglycemia and Glucagon
152
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
152
Insulin: Dosing Regimen and Adverse Effects
145
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
145


